NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 03:33PM ET
5.42
Dollar change
+0.25
Percentage change
4.84
%
IndexRUT P/E- EPS (ttm)-2.19 Insider Own1.18% Shs Outstand26.43M Perf Week5.86%
Market Cap134.63M Forward P/E- EPS next Y-0.42 Insider Trans8.71% Shs Float24.55M Perf Month-7.51%
Enterprise Value152.88M PEG- EPS next Q-0.25 Inst Own28.51% Short Float18.27% Perf Quarter-30.60%
Income-57.05M P/S1.88 EPS this Y11.72% Inst Trans9.02% Short Ratio15.54 Perf Half Y-58.97%
Sales71.66M P/B- EPS next Y79.89% ROA-68.34% Short Interest4.49M Perf YTD-57.66%
Book/sh-0.17 P/C5.21 EPS next 5Y- ROE-407.50% 52W High14.16 -61.72% Perf Year-29.79%
Cash/sh1.04 P/FCF- EPS past 3/5Y-26.79% -88.92% ROIC-144.41% 52W Low4.71 15.07% Perf 3Y3.83%
Dividend Est.- EV/EBITDA- Sales past 3/5Y30.02% 63.43% Gross Margin85.47% Volatility6.49% 6.10% Perf 5Y-79.23%
Dividend TTM- EV/Sales2.13 EPS Y/Y TTM-24.61% Oper. Margin-71.44% ATR (14)0.37 Perf 10Y-2.34%
Dividend Ex-Date- Quick Ratio1.72 Sales Y/Y TTM41.35% Profit Margin-79.61% RSI (14)43.62 Recom1.88
Dividend Gr. 3/5Y- - Current Ratio2.09 EPS Q/Q27.46% SMA20-0.58% Beta1.63 Target Price14.63
Payout- Debt/Eq- Sales Q/Q66.73% SMA50-20.14% Rel Volume0.79 Prev Close5.17
Employees260 LT Debt/Eq- EarningsMay 08 AMC SMA200-42.90% Avg Volume288.74K Price5.42
IPOMar 29, 2012 Option/ShortYes / Yes EPS/Sales Surpr.-72.41% -10.78% Trades Volume212,463 Change4.84%
Date Action Analyst Rating Change Price Target Change
Dec-24-24Initiated D. Boral Capital Buy $25
Apr-11-24Downgrade BTIG Research Buy → Neutral
Jun-27-23Initiated Cantor Fitzgerald Overweight $23
Mar-02-21Initiated Piper Sandler Overweight $27
Aug-27-20Initiated BofA Securities Buy $42
Apr-21-20Initiated Oppenheimer Outperform $9
Mar-03-20Initiated BTIG Research Buy $10
Jun-09-25 09:00AM
Jun-05-25 04:04PM
Jun-03-25 08:00PM
May-13-25 09:00AM
May-08-25 04:03PM
09:00AM Loading…
Apr-24-25 09:00AM
Apr-17-25 04:05PM
Apr-09-25 04:05PM
Apr-03-25 04:03PM
Mar-17-25 04:05PM
Mar-13-25 09:55AM
Feb-26-25 05:30PM
Feb-20-25 10:46AM
09:55AM
Feb-14-25 09:15AM
04:01PM Loading…
Feb-13-25 04:01PM
Jan-09-25 02:04PM
Jan-07-25 04:35PM
Dec-25-24 07:45AM
07:20AM
Dec-24-24 07:35AM
Dec-23-24 04:02PM
Dec-19-24 05:05PM
Dec-18-24 04:08PM
Dec-10-24 10:37PM
Nov-30-24 07:18PM
Nov-25-24 04:02PM
Nov-12-24 04:03PM
Nov-08-24 09:00AM
Nov-07-24 04:03PM
05:15PM Loading…
Oct-10-24 05:15PM
Sep-12-24 04:05PM
Sep-10-24 04:03PM
Aug-30-24 10:33AM
Aug-09-24 06:37AM
Aug-08-24 07:00PM
04:04PM
Aug-01-24 04:05PM
05:32AM
Jul-31-24 04:05PM
Jul-11-24 04:10PM
Jul-01-24 04:05PM
Jun-05-24 04:25PM
May-31-24 06:55AM
May-30-24 09:15AM
May-16-24 06:30PM
May-14-24 08:57AM
03:04AM
May-13-24 09:55PM
04:01PM
May-12-24 09:16AM
Apr-15-24 05:05PM
Apr-10-24 05:11PM
Feb-29-24 04:02PM
09:00AM
Feb-23-24 10:45AM
09:01AM
Feb-22-24 04:45PM
04:01PM
Feb-01-24 04:10PM
Jan-10-24 04:01PM
09:01AM
Jan-04-24 09:00AM
Dec-04-23 09:00AM
Nov-21-23 04:15PM
Nov-20-23 04:15PM
Nov-10-23 03:04PM
Nov-09-23 04:01PM
09:00AM
Oct-19-23 04:05PM
Oct-18-23 09:00AM
Oct-02-23 02:37PM
Sep-25-23 08:00AM
Sep-21-23 04:30PM
Sep-06-23 06:45PM
Aug-14-23 08:00AM
Aug-12-23 09:44AM
Aug-10-23 04:01PM
Jul-20-23 04:05PM
Jul-16-23 07:34PM
Jul-14-23 06:59AM
Jun-29-23 06:21PM
Jun-26-23 08:00AM
Jun-22-23 07:05AM
Jun-16-23 02:47PM
Jun-15-23 04:05PM
Jun-08-23 02:25PM
Jun-07-23 08:00PM
May-25-23 05:15PM
May-15-23 06:31PM
May-11-23 04:12PM
May-04-23 09:40PM
Apr-21-23 08:50AM
Apr-20-23 04:30PM
10:14AM
Apr-19-23 12:00PM
Apr-13-23 05:35PM
Apr-12-23 12:34PM
Apr-08-23 07:24PM
Apr-04-23 08:50AM
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McNamara RobertDirectorMar 06 '25Buy8.3011,00091,30056,749Mar 10 04:30 PM
McNamara RobertDirectorFeb 20 '25Buy10.0910,000100,90045,749Feb 20 04:30 PM
O'Toole David DCFOFeb 20 '25Buy9.901,0009,90025,734Feb 20 04:30 PM
O'Toole David DCFOFeb 19 '25Buy10.251,00010,25024,734Feb 19 04:30 PM
Crowe SuzanneDirectorDec 09 '24Buy13.154866,39136,912Jan 29 04:57 PM
O'Toole David DCFODec 05 '24Buy12.4697512,15223,734Dec 05 05:00 PM